About AIRE Medical of Los Angeles
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at AIRE Medical of Los Angeles
During the past decade, AIRE Medical of Los Angeles conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery
1998-11-01
2004-05-01
Completed
16
Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer
2003-07-01
2009-08-01
Completed
57
Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
2004-06-01
2007-05-01
Completed
Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes
2005-01-01
2008-08-01
Completed
151
Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
2005-07-01
2014-07-01
Completed
724
Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML
2005-06-01
2013-06-01
Completed
638
Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)
2005-06-01
2010-11-01
Terminated
476
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "AIRE Medical of Los Angeles"
#1 collaborator was "Takeda Development Center Americas, Inc." with 3 trials as a collaborator and "Dyax Corp." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at AIRE Medical of Los Angeles
According to Clinical.Site data, the most researched conditions in "AIRE Medical of Los Angeles" are
"Hereditary Angioedema (HAE)" (5 trials), "Angioedema" (2 trials), "Hereditary Angioedema" (2 trials) and "Primary Immunodeficiency" (1 trials). Many other conditions were trialed in "AIRE Medical of Los Angeles" in a lesser frequency.
Clinical Trials Intervention Types at AIRE Medical of Los Angeles
Most popular intervention types in "AIRE Medical of Los Angeles" are "Drug" (7 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Lanadelumab" (2 trials), "C1 esterase inhibitor [human] liquid" (1 trials), "DX-2930" (1 trials) and "DX-2930 - 150mg/4wk" (1 trials). Other intervention names were less common.
Clinical Trials Genders at AIRE Medical of Los Angeles
The vast majority of trials in "AIRE Medical of Los Angeles" are
9 trials for "All" genders.
Clinical Trials Status at AIRE Medical of Los Angeles
Currently, there are NaN active trials in "AIRE Medical of Los Angeles".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in AIRE Medical of Los Angeles,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in AIRE Medical of Los Angeles, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".